What if existing medicines could unlock entirely new treatments? Could drug development become faster, more cost-effective, and less risky? By leveraging AI to reveal hidden opportunities across the world’s biomedical knowledge, effective drug repurposing has the potential to deliver safe, life-changing therapies to patients—faster than ever before.
To explore this important topic, Elsevier is pleased to invite you to our upcoming webinar:
Join leading organizations including Every Cure, Rare Hope foundation, and Cure Sanfilippo foundation as they share cutting-edge research, innovative approaches, and practical strategies for effective drug repurposing.
AGENDA
From Chasing My Cure to Every Cure
Connecting the Dots: Leveraging the Embiology Knowledge Graph and Multidisciplinary Collaboration for Drug Repurposing in Rare Disease
Advancing Rare Disease Research through AI and smarter data
Panel discussion and live Q&A
ADDITIONAL INFO
When:
Wednesday, October 8, 2025 · 4:00 p.m.
Amsterdam
Nina leads the international research program for Alternating Hemiplegia of Childhood (AHC), uniting multiple AHC patient organizations around the world. Nina has spearheaded the design, centralization, and management of a strategic portfolio of...
David Fajgenbaum, MD, MBA, MSc, is Co-Founder and President of Every Cure and a physician-scientist at the University of Pennsylvania, where he is one of the youngest faculty members ever to receive tenure at Penn Medicine. A patient battling a...
Chief Scientific Officer, Cure Sanfilippo Foundation
Cara O’Neill completed her medical education at West Virginia University School of Medicine and subsequently her Pediatric Residency training at the University of South Carolina. She has worked both in private practice and academic settings....
Tom has over 20 years of experience in biological and pharmaceutical sciences, spanning multiple continents and roles in research, consulting, and education. He holds a PhD in pharmaceutical science and Master's degrees in business and biology. He...